These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1389933)

  • 21. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
    Rambeck B; May T; Juergens U
    Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites.
    Muñoz JJ; De Salamanca RE; Diaz-Obregón C; Timoneda FL
    Br J Clin Pharmacol; 1990 Jun; 29(6):763-5. PubMed ID: 2378792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
    Brodie MJ; Forrest G; Rapeport WG
    Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutual interaction between remacemide hydrochloride and carbamazepine: two drugs with active metabolites.
    Leach JP; Blacklaw J; Jamieson V; Jones T; Richens A; Brodie MJ
    Epilepsia; 1996 Nov; 37(11):1100-6. PubMed ID: 8917061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of sex, age, weight, and carbamazepine dose on serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites.
    Liu H; Delgado MR
    Ther Drug Monit; 1994 Oct; 16(5):469-76. PubMed ID: 7846744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine, with valproate: a pharmacokinetic study.
    Pisani F; Caputo M; Fazio A; Oteri G; Russo M; Spina E; Perucca E; Bertilsson L
    Epilepsia; 1990; 31(3):339-42. PubMed ID: 2111769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
    Eichelbaum M; Tomson T; Tybring G; Bertilsson L
    Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.
    Mahmood I; Chamberlin N
    Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple-dose pharmacokinetic study with a slow-release carbamazepine preparation.
    Reunanen M; Heinonen E; Anttila M; Järvensivu P; Lehto H; Hokkanen E
    Epilepsy Res; 1990 Jul; 6(2):126-33. PubMed ID: 2387286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoinduction of carbamazepine metabolism in children examined by a stable isotope technique.
    Bertilsson L; Höjer B; Tybring G; Osterloh J; Rane A
    Clin Pharmacol Ther; 1980 Jan; 27(1):83-8. PubMed ID: 7351120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid reversibility of autoinduction of carbamazepine metabolism after temporary discontinuation.
    Schäffler L; Bourgeois BF; Lüders HO
    Epilepsia; 1994; 35(1):195-8. PubMed ID: 8112245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
    Nakajima Y; Saito Y; Shiseki K; Fukushima-Uesaka H; Hasegawa R; Ozawa S; Sugai K; Katoh M; Saitoh O; Ohnuma T; Kawai M; Ohtsuki T; Suzuki C; Minami N; Kimura H; Goto Y; Kamatani N; Kaniwa N; Sawada J
    Eur J Clin Pharmacol; 2005 Mar; 61(1):25-34. PubMed ID: 15692831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of blood platelet count during carbamazepine and oxcarbazepine treatment with daily dose, and serum concentrations of carbamazepine, carbamazepine-10, 11-epoxide, and 10-hydroxycarbazepine.
    Tutor-Crespo MJ; Hermida J; Tutor JC
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):91-4. PubMed ID: 17690747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
    Macphee GJ; Butler E; Brodie MJ
    Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No effect of thioridazine on plasma concentrations of carbamazepine and its active metabolite carbamazepine-10,11-epoxide.
    Spina E; Amendola D'Agostino AM; Ioculano MP; Oteri G; Fazio A; Pisani F
    Ther Drug Monit; 1990 Sep; 12(5):511-3. PubMed ID: 2293416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Problem of spurious correlation in the evaluation of steady-state carbamazepine levels using metabolite data.
    van Belle G; Friel PN
    Ther Drug Monit; 1986; 8(2):177-83. PubMed ID: 3726931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simulation of the effect of patient nonadherence on plasma concentrations of carbamazepine from twice-daily extended-release capsules.
    Garnett WR; McLean AM; Zhang Y; Clausen S; Tulloch SJ
    Curr Med Res Opin; 2003; 19(6):519-25. PubMed ID: 14594524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.